Hesperadin Suppresses Pancreatic Cancer through ATF4/GADD45A Axis at Nanomolar Concentrations

Hesperadin induced potent growth inhibition in pancreatic cancer cell lines and patient-derived tumor organoids in a dose- and time-dependent manner, with IC50 values in the nanomolar range.